Global Clinical Next-generation Sequencing Market

Global Clinical Next-generation Sequencing Market

Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

RELEASE DATE
24-Dec-2015
REGION
North America
Research Code: 9AB9-00-46-00-00
SKU: LS00160-NA-MR_17130

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00160-NA-MR_17130

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.

Table of Contents

Market Outlook

Current Regulatory Status of NGS Instruments

Evolution of NGS Testing

NGS for Clinical versus Research Applications

Market Outlook on NGS Clinical Markets—Global

NGS Clinical Landscape—China

NGS Clinical Landscape—United States

Untapped Market for Clinical Applications of NGS—Global

Opportunity Assessment for Clinical NGS

Use of NGS Technology—Global

NGS-based Companion Diagnostics a Near-term Possibility

Points to Consider

Current Protocols for Reimbursement

Success Stories of 3 Companies—What Drives Reimbursement?

Genomic Health

Veracyte

Veracyte (Illumina)

Summary of Reimbursement Coverage Best Practices

Top Bottlenecks

Lessons from Early Adopters

Survey on Clinical NGS

Survey on Clinical NGS (continued)

Key Conclusions and Future Outlook

Analysis from the Genetic Test Repository (GTR)

Test Purpose

Test Method—NGS, Microarray, Sanger, and CGH Based

Tests Offered By Location

Tests Offered By Location (continued)

Selected NGS-based Tests with Clinical Significance

Selected NGS-based Tests with Clinical Significance (continued)

Selected NGS-based Tests with Clinical Significance (continued)

NGS Clinical Test Provider Profiles

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

NGS Clinical Test Provider Profiles (continued)

List for DTC Genetic Testing

List for DTC Genetic Testing (continued)

List for DTC Genetic Testing (continued)

List for DTC Genetic Testing (continued)

List for DTC Genetic Testing (continued)

FDA’s Warning Letters to Manufacturers

List of Approved Companion Diagnostic Kits

List of Approved Companion Diagnostic Kits (continued)

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.
More Information
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number 9AB9-00-46-00-00
Is Prebook No